Using virtual mapping to improve catheter ablation for atrial fibrillation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of virtual rotor mapping in guiding catheter ablation for patients with paroxysmal atrial fibrillation. By creating a patient-specific 3D atrial model, the researchers aim to enhance the precision of the ablation procedure and reduce recurrence rates. The study will compare outcomes from traditional circumferential pulmonary vein isolation with those from additional rotor ablation informed by the virtual mapping technique. The goal is to determine if this innovative approach leads to better clinical results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* AF patient age 19\~80
* Diagnosis of AF patients who performed catheter ablation of atrial fibrillation due to uncontrolled pulse rate by anti-arrhythmic drug therapy.

Exclusion Criteria:

* AF patients who have severe heart deformations or vascular disease.
* The patient who have renal disease of eGFR\<30mL/min
* The patients who had been performed catheter ablation of atrial ablation and MAZE.
* The patients who missed out to recording of 3D CT, echo and electrocardiography.
* the patient have experienced major hemorrhagic complication
* The patient have experienced ischemic cerebral infarction more 2 times
* The patient who have risk of ischemic cerebral infarction (CHA2DS2-VASc Score \>5)

Where it's running

• Severance Cardiovascular Hospital, Yonsei University Health System
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: Hui-Nam Pak
• Email: hnpak@yuhs.ac
• Phone: 82-2-2228-8459

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Conscious Sedation vs General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation

  This trial tests whether local anesthesia with conscious sedation can match general anesthesia for pulsed field ablation in adults with paroxysmal atrial fibrillation.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07877519

• Pulsed field ablation for atrial fibrillation in underrepresented minority patients

  This registry will test how well Boston Scientific pulsed field ablation works and how safe it is for Black, Hispanic, Asian, and other underrepresented adults with paroxysmal or persistent atrial fibrillation.

  Recruiting at 2 sites Icahn School of Medicine at Mount Sinai · New York, New York and 1 other locations · NCT07535268

• FARAPULSE pulsed-field waveform treatment for paroxysmal and persistent atrial fibrillation

  This will test new pulsed electrical waveforms delivered by the FARAPULSE PFA system to treat adults with paroxysmal or persistent atrial fibrillation.

  Recruiting at 3 sites Boston Scientific Corporation · Split and 3 other locations · NCT07444320

• Factors that affect atrial tracking and atrial fibrillation in people receiving the Micra AV2 pacemaker

  This will see how well the Micra AV2 device tracks atrial activity and how often short episodes of paroxysmal atrial fibrillation occur in adults who receive the device.

  Recruiting Northwell Health · New Hyde Park, New York · NCT07344961

• Burst stimulation with pulmonary vein and superior vena cava isolation for paroxysmal atrial fibrillation

  This will try burst electrical stimulation together with pulmonary vein and superior vena cava isolation to lower the chance that paroxysmal atrial fibrillation comes back after a first catheter ablation in adults.

  Recruiting at 3 sites Zhongnan Hospital · Wuhan, Hubei and 2 other locations · NCT07281898

• Arrhythmia mapping with a paddle-shaped multi-electrode catheter

  This test uses a new high-density multi-electrode catheter to see if it can safely map atrial and ventricular arrhythmias in adults having catheter mapping and ablation.

  Recruiting at 5 sites Biosense Webster, Inc. · Bruges and 4 other locations · NCT07116525

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.